1139. Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Compared to a Meningococcal Reference Vaccine (MCV4-TT) in Healthy Adolescents

BACKGROUND: MenACYW-TT (MenQuadfi(®)) is a quadrivalent meningococcal conjugate vaccine licensed for use in individuals ≥ 12 months age in the EU and certain other countries and ≥ 2 years of age in the US. Safety and immunogenicity of a single dose of MenACYW-TT were evaluated in 10-17 years old hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Díez-Domingo, Javier, Simkó, Róbert, Icardi, Giancarlo, Chong, Chan Poh, Zocchetti, Céline, Syrkina, Olga, Bchir, Siham, Bertrand-Gerentes, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677521/
http://dx.doi.org/10.1093/ofid/ofad500.980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677521/
http://dx.doi.org/10.1093/ofid/ofad500.980

Ejemplares similares